| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.14 | 3e-05 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.28 | 0.0001 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0009 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |